News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BIND Therapeutics Awarded the RUSNANOPRIZE 2013 for Innovative Development of Nanomedicine



11/4/2013 10:02:20 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND Therapeutics Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that BIND has been awarded the RUSNANOPRIZE 2013 for Innovative Development by the International Prize Award Committee. This award recognizes BIND for its translation of state-of-the-art nanoparticle technology into clinical-stage development. The award ceremony was held at the Moscow International Forum for Open Innovation in Moscow on November 1, 2013.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES